Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senthil Selvaraj

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Journal of Cardiovascular Translational Research|March 5, 2017
Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection FractionDaniel H Katz, Rahul C Deo, Frank G Aguilar, et al.
Journal of the American Heart Association|May 1, 2014
Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN studySenthil Selvaraj, Frank G Aguilar, Eva E Martinez, et al.
Circulation|October 1, 2013
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) studyDaniel H Katz, Senthil Selvaraj, Frank G Aguilar, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
NPJ Genomic Medicine|February 16, 2022
A population study of clinically actionable genetic variation affecting drug response from the Middle EastPuthen Veettil Jithesh, Mohammed Abuhaliqa, Najeeb Syed, et al.
JACC. Heart Failure|January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVERSenthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Advances|June 27, 2025
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HFAndrew J Sauer, Joycie Chang, Zhuxuan Fu, et al.
Circulation|May 23, 2022
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HFSenthil Selvaraj, Zhuxuan Fu, Philip Jones, et al.
Human Mutation|February 3, 2022
Qatar genome: Insights on genomics from the Middle EastHamdi Mbarek, Geethanjali Devadoss Gandhi, Senthil Selvaraj, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Journal of Cardiovascular Translational Research|March 5, 2017
Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection FractionDaniel H Katz, Rahul C Deo, Frank G Aguilar, et al.
Journal of the American Heart Association|May 1, 2014
Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN studySenthil Selvaraj, Frank G Aguilar, Eva E Martinez, et al.
Circulation|October 1, 2013
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) studyDaniel H Katz, Senthil Selvaraj, Frank G Aguilar, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
NPJ Genomic Medicine|February 16, 2022
A population study of clinically actionable genetic variation affecting drug response from the Middle EastPuthen Veettil Jithesh, Mohammed Abuhaliqa, Najeeb Syed, et al.
JACC. Heart Failure|January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVERSenthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Advances|June 27, 2025
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HFAndrew J Sauer, Joycie Chang, Zhuxuan Fu, et al.
Circulation|May 23, 2022
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HFSenthil Selvaraj, Zhuxuan Fu, Philip Jones, et al.
Human Mutation|February 3, 2022
Qatar genome: Insights on genomics from the Middle EastHamdi Mbarek, Geethanjali Devadoss Gandhi, Senthil Selvaraj, et al.
Pageof 12